Organigram Reports Q2 2022 Revenues Of $30.4 Million, Positive Gross Margins

Organigram Holdings (TSX: OGI) has finally done it. The company has finally posted a positive gross margin quarter, although just barely. The firm this morning reported its fiscal first quarter results for 2022, posting net revenue of $30.4 million.

The quarterly results were a substantial improvement on a quarter over quarter basis, with sales rising 22.2% on a quarter over quarter basis from $24.9 million in the fourth quarter, while also taking a spot as the #4 market share position in the Canadian cannabis sector. Gross margin before adjustments came in at $2.5 million, the first positive gross margin quarter exhibited by the company in well over a year – and all it took was the highest net revenue quarter in the firms history.

This move to positive gross margin however was not enough to get the company into the black, with the firm reporting operating expenses of $14.3 million, lead by G&A of $8.0 million, resulting in a loss from operations of $13.7 million.

This loss however was given a boost from other income, with the company reporting a $12.7 million boost from the change in fair value of derivative liabilities, with the company posting an overall net loss of just $1.3 million as a result. Adjusted EBITDA meanwhile came in at a loss of $1.9 million.

Cash over the quarter meanwhile climbed to $99.7 million from $55.4 million, while short term investments halved from $128.2 million to $68.3 million.

Looking forward, the company expects second quarter revenues to be “significantly higher” than Q2 2021, wherein the firm reported net revenues of $14.6 million. Gross margin meanwhile is expected to improve sequentially.

Organigram Holdings last traded at $2.19 on the TSX.


Information for this briefing was found via Sedar and Organigram Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Organigram: Consensus Analyst Estimates For Q2 2021

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April...

Saturday, April 10, 2021, 01:35:00 PM

Federal Wage Subsidies Granted to Publicly Traded Cannabis Companies Eclipses $100 Million

On June 1, 2021, total wage subsidies doled out to publicly traded cannabis companies from...

Wednesday, June 2, 2021, 02:30:00 PM

Organigram Sees BAT Plan To Increase Stake To 45% With $124 Million Investment

While Canopy Growth (TSX: WEED) may have lost the interest of its major investor Constellation...

Monday, November 6, 2023, 09:04:39 AM

Organigram Reports Second Quarter of Declining Revenues, Negative Gross Margin

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced its second straight quarter of declining revenues this...

Monday, November 25, 2019, 08:57:36 AM

Organigram Posts Q4 Loss Of $26.0 Million

Organigram Holdings (TSX: OGI) this morning reported its fiscal fourth quarter financial results, posting net...

Tuesday, November 23, 2021, 08:52:01 AM